Australia
· Delayed Price · Currency is AUD Invex Therapeutics Statistics
Total Valuation
ASX:IXC has a market cap or net worth of AUD 6.99 million. The enterprise value is 1.18 million.
| Market Cap | 6.99M |
| Enterprise Value | 1.18M |
Important Dates
The last earnings date was Wednesday, May 7, 2025.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:IXC has 75.15 million shares outstanding. The number of shares has increased by 0.62% in one year.
| Current Share Class | 75.15M |
| Shares Outstanding | 75.15M |
| Shares Change (YoY) | +0.62% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 26.31% |
| Owned by Institutions (%) | 26.51% |
| Float | 48.16M |
Valuation Ratios
The trailing PE ratio is 61.55.
| PE Ratio | 61.55 |
| Forward PE | n/a |
| PS Ratio | 5.77 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 10.34 |
| EV / Sales | 0.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.22
| Current Ratio | 12.22 |
| Quick Ratio | 12.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.14% and return on invested capital (ROIC) is -1.36%.
| Return on Equity (ROE) | 2.14% |
| Return on Assets (ROA) | -1.20% |
| Return on Invested Capital (ROIC) | -1.36% |
| Return on Capital Employed (ROCE) | -2.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.68% in the last 52 weeks. The beta is 0.01, so ASX:IXC's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | +23.68% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 72.00 |
| Average Volume (20 Days) | 39,435 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:IXC had revenue of AUD 1.21 million and earned 114,355 in profits. Earnings per share was 0.00.
| Revenue | 1.21M |
| Gross Profit | 1.21M |
| Operating Income | -116,470 |
| Pretax Income | 114,355 |
| Net Income | 114,355 |
| EBITDA | n/a |
| EBIT | -116,470 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 5.81 million in cash and n/a in debt, giving a net cash position of 5.81 million or 0.08 per share.
| Cash & Cash Equivalents | 5.81M |
| Total Debt | n/a |
| Net Cash | 5.81M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 5.38M |
| Book Value Per Share | 0.07 |
| Working Capital | 5.38M |
Cash Flow
| Operating Cash Flow | -368,362 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -9.61% and 9.43%.
| Gross Margin | 100.00% |
| Operating Margin | -9.61% |
| Pretax Margin | 9.43% |
| Profit Margin | 9.43% |
| EBITDA Margin | n/a |
| EBIT Margin | -9.61% |
| FCF Margin | n/a |
Dividends & Yields
ASX:IXC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.62% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.64% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:IXC has an Altman Z-Score of 3.88.
| Altman Z-Score | 3.88 |
| Piotroski F-Score | n/a |